KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $17.6 million.

  • Global Medical REIT's Free Cash Flow rose 22978.2% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$48.4 million, marking a year-over-year decrease of 23876.68%. This contributed to the annual value of -$11.6 million for FY2024, which is 11756.23% down from last year.
  • Latest data reveals that Global Medical REIT reported Free Cash Flow of $17.6 million as of Q3 2025, which was up 22978.2% from -$16.4 million recorded in Q2 2025.
  • Global Medical REIT's 5-year Free Cash Flow high stood at $19.4 million for Q2 2024, and its period low was -$54.4 million during Q2 2021.
  • Over the past 5 years, Global Medical REIT's median Free Cash Flow value was -$9.2 million (recorded in 2021), while the average stood at -$8.5 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 145748.5% in 2021, then skyrocketed by 29474.48% in 2022.
  • Global Medical REIT's Free Cash Flow (Quarter) stood at -$9.2 million in 2021, then surged by 294.74% to $18.0 million in 2022, then dropped by 7.59% to $16.6 million in 2023, then crashed by 279.87% to -$29.9 million in 2024, then surged by 158.8% to $17.6 million in 2025.
  • Its Free Cash Flow stands at $17.6 million for Q3 2025, versus -$16.4 million for Q2 2025 and -$19.7 million for Q1 2025.